DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Meijers-Heijboer H, van den Ouweland A, Klijn J. et al.
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Nat Genet 2002;
31: 55-59
We do not assume any responsibility for the contents of the web pages of other providers.